A retrospective study of Medicare data showed a potential factor in nonadherence to oral cancer treatment regimens.
Men nearly always outnumbered women, regardless of trial phase, cancer type, time period, or cancer incidence in the female population.
Responses in cancer patients were noninferior to responses in patients without cancer.
Researchers found preoperative blood glucose levels were associated with hospital length of stay for patients undergoing laparoscopic nephrectomy for RCC.
As first-line therapy for advanced renal cell carcinoma, nivolumab plus cabozantinib prolongs progression-free survival compared with sunitinib in patients with and without a prior nephrectomy.
Five-year survival rates following nephrectomy for renal cell carcinoma are higher among patients with favorable vs unfavorable histology.
New study findings “are critically important in patient counseling and surgical planning, particularly for patients with risk factors for renal deterioration,” according to investigators.
Investigators concluded that there is minimal to no clinical value in surveillance for pulmonary recurrence after T1a RCC resection.
The approval was based on data from an open-label phase 2 study which evaluated the efficacy and safety of Welireg in patients with von Hippel-Lindau-associated renal cell carcinoma and other VHL-associated tumors.
Researchers concluded that pembrolizumab plus axitinib may be the most effective first-line immunotherapy for mRCC